Comparison of Cervical Cancer Screening Results Among 256,648 Women in Multiple Clinical Practices

In the United States, human papillomavirus (HPV) and Papanicolaou (Pap) testing (cotesting) for cervical
screening in women ages 30 to 65 years is the preferred strategy, and cytology alone is acceptable. Recently, a proprietary automated test for identifying high-risk HPV types for primary cervical screening …